Name | 6-amino-1,3-dibutyl-5-nitrosopyrimidine-2,4-dione |
---|---|
Synonyms |
6-amino-1,3-di-n-butyl-5-nitroso-uracil
6-amino-1,3-dibutyl-5-nitroso-1,2,3,4-tetrahydropyrimidine-2,4-dione 6-amino-1,3-dibutyl-5-nitroso-1H-pyrimidine-2,4-dione 6-Amino-1,3-dibutyl-5-nitroso-1H-pyrimidin-2,4-dion 1,3-Dibutyl-5-nitroso-6-amino-uracil 6-amino-1,3-dibutyl-5-nitrosouracil |
Molecular Formula | C12H20N4O3 |
---|---|
Molecular Weight | 268.31200 |
Exact Mass | 268.15400 |
PSA | 99.45000 |
LogP | 2.17150 |
HS Code | 2933599090 |
---|
~84% 132716-86-0 |
Literature: The United States of America as represented by the Department of Health and Human Services Patent: US5773423 A1, 1998 ; US 5773423 A |
~% 132716-86-0 |
Literature: Journal of Medicinal Chemistry, , vol. 49, # 12 p. 3682 - 3692 |
~% 132716-86-0 |
Literature: Journal of Medicinal Chemistry, , vol. 37, # 20 p. 3373 - 3382 |
Precursor 2 | |
---|---|
DownStream 3 | |
HS Code | 2933599090 |
---|---|
Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |